• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童脊髓性肌萎缩症中的异常脂肪酸代谢。

Abnormal fatty acid metabolism in childhood spinal muscular atrophy.

作者信息

Crawford T O, Sladky J T, Hurko O, Besner-Johnston A, Kelley R I

机构信息

Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.

出版信息

Ann Neurol. 1999 Mar;45(3):337-43. doi: 10.1002/1531-8249(199903)45:3<337::aid-ana9>3.0.co;2-u.

DOI:10.1002/1531-8249(199903)45:3<337::aid-ana9>3.0.co;2-u
PMID:10072048
Abstract

Our previous experience with abnormal fatty acid metabolism in several children with spinal muscular atrophy (SMA) prompted evaluation of fatty acid metabolism in a larger cohort. Thirty-three infants with severe infantile SMA were shown to have a significantly increased ratio of dodecanoic to tetradecanoic acid in plasma compared with normal infants and 6 infants affected with equally debilitating, non-SMA denervating disorders. Seventeen children with milder forms of SMA had normal fatty acid profiles. In addition, all 5 infants with severe SMA evaluated in a fasting state developed a distinctive and marked dicarboxylic aciduria, including saturated, unsaturated, and 3-hydroxy forms, comparable in severity with the dicarboxylic aciduria of children with primary defects of mitochondrial fatty acid beta-oxidation. Nine children with chronic SMA and 23 control patients did not develop an abnormal dicarboxylic aciduria during fasting. No known disorder of fatty acid metabolism explains all of the abnormalities we find in SMA. Our data suggest, however, that the abnormalities are not a consequence of SMA-related immobility, systemic illness, muscle denervation, or muscle atrophy. These abnormalities in fatty acid metabolism may be caused by changes in cellular physiology related to the molecular defects of the SMA-pathogenic survival motor neuron gene or neighboring genes.

摘要

我们之前对几名脊髓性肌萎缩症(SMA)患儿异常脂肪酸代谢的研究经验促使我们对更大队列的脂肪酸代谢情况进行评估。与正常婴儿以及6名患有同样严重的非SMA去神经疾病的婴儿相比,33名重度婴儿型SMA婴儿的血浆中十二烷酸与十四烷酸的比例显著升高。17名症状较轻的SMA患儿的脂肪酸谱正常。此外,所有5名在禁食状态下接受评估的重度SMA婴儿均出现了独特且明显的二羧酸尿症,包括饱和、不饱和及3 - 羟基形式,其严重程度与线粒体脂肪酸β氧化原发性缺陷患儿的二羧酸尿症相当。9名慢性SMA患儿和23名对照患者在禁食期间未出现异常二羧酸尿症。目前已知的脂肪酸代谢紊乱均无法解释我们在SMA中发现的所有异常情况。然而,我们的数据表明,这些异常并非SMA相关的活动受限、全身性疾病、肌肉去神经支配或肌肉萎缩所致。脂肪酸代谢的这些异常可能是由与SMA致病存活运动神经元基因或邻近基因的分子缺陷相关的细胞生理变化引起的。

相似文献

1
Abnormal fatty acid metabolism in childhood spinal muscular atrophy.儿童脊髓性肌萎缩症中的异常脂肪酸代谢。
Ann Neurol. 1999 Mar;45(3):337-43. doi: 10.1002/1531-8249(199903)45:3<337::aid-ana9>3.0.co;2-u.
2
Abnormal fatty acid metabolism is a core component of spinal muscular atrophy.脂肪酸代谢异常是脊髓性肌肉萎缩症的核心组成部分。
Ann Clin Transl Neurol. 2019 Aug;6(8):1519-1532. doi: 10.1002/acn3.50855. Epub 2019 Jul 26.
3
Fatty acid oxidation abnormalities in childhood-onset spinal muscular atrophy: primary or secondary defect(s)?儿童期起病的脊髓性肌萎缩症中的脂肪酸氧化异常:原发性还是继发性缺陷?
Pediatr Neurol. 1995 Jan;12(1):21-30. doi: 10.1016/0887-8994(94)00100-g.
4
Distinction of dicarboxylic aciduria due to medium-chain triglyceride feeding from that due to abnormal fatty acid oxidation and fasting in children.
Metabolism. 1996 Feb;45(2):162-7. doi: 10.1016/s0026-0495(96)90047-5.
5
Cardiac pathology in spinal muscular atrophy: a systematic review.脊髓性肌萎缩症的心脏病理学:一项系统综述
Orphanet J Rare Dis. 2017 Apr 11;12(1):67. doi: 10.1186/s13023-017-0613-5.
6
Vascular Defects and Spinal Cord Hypoxia in Spinal Muscular Atrophy.血管缺陷和脊髓缺氧在脊髓性肌萎缩症。
Ann Neurol. 2016 Feb;79(2):217-30. doi: 10.1002/ana.24549. Epub 2016 Jan 13.
7
Established Stem Cell Model of Spinal Muscular Atrophy Is Applicable in the Evaluation of the Efficacy of Thyrotropin-Releasing Hormone Analog.已建立的脊髓性肌萎缩症干细胞模型可用于评估促甲状腺激素释放激素类似物的疗效。
Stem Cells Transl Med. 2016 Feb;5(2):152-63. doi: 10.5966/sctm.2015-0059. Epub 2015 Dec 18.
8
Muscle strength and motor function throughout life in a cross-sectional cohort of 180 patients with spinal muscular atrophy types 1c-4.180 例脊髓性肌萎缩症 1c-4 型患者的横断面队列研究中贯穿一生的肌肉力量和运动功能。
Eur J Neurol. 2018 Mar;25(3):512-518. doi: 10.1111/ene.13534. Epub 2018 Feb 2.
9
Oxidative stress and disturbed glutamate transport in spinal muscular atrophy.脊髓性肌萎缩症中的氧化应激与谷氨酸转运紊乱
Brain Dev. 2002 Dec;24(8):770-5. doi: 10.1016/s0387-7604(02)00103-1.
10
[Clinical, electrophysiological and molecular study of 26 chilean patients with spinal muscular atrophy].26例智利脊髓性肌萎缩症患者的临床、电生理及分子研究
Rev Med Chil. 2011 Feb;139(2):197-204. Epub 2011 Jul 11.

引用本文的文献

1
Comorbidities in spinal muscular atrophy and their impact on the course of the underlying disease: a real-life observational study.脊髓性肌萎缩症的合并症及其对基础疾病病程的影响:一项真实世界观察性研究
BMC Musculoskelet Disord. 2025 Sep 2;26(1):839. doi: 10.1186/s12891-025-09133-6.
2
Alterations of Fat and Ketone Body Metabolism in ALS and SMA-A Prospective Observational Study.肌萎缩侧索硬化症和脊髓性肌萎缩症中脂肪和酮体代谢的改变——一项前瞻性观察研究
Eur J Neurol. 2025 Apr;32(4):e70132. doi: 10.1111/ene.70132.
3
Impact of liver-specific survival motor neuron (SMN) depletion on central nervous system and peripheral tissue pathology.
肝脏特异性生存运动神经元(SMN)缺失对中枢神经系统和外周组织病理学的影响。
Elife. 2025 Feb 20;13:RP99141. doi: 10.7554/eLife.99141.
4
Multi-omics profiling in spinal muscular atrophy (SMA): investigating lipid and metabolic alterations through longitudinal CSF analysis of Nusinersen-treated patients.脊髓性肌萎缩症(SMA)的多组学分析:通过对接受诺西那生治疗患者的脑脊液进行纵向分析来研究脂质和代谢改变
J Neurol. 2025 Feb 4;272(3):183. doi: 10.1007/s00415-025-12909-4.
5
Alterations in cardiac function correlate with a disruption in fatty acid metabolism in a mouse model of SMA.在脊髓性肌萎缩症小鼠模型中,心脏功能的改变与脂肪酸代谢紊乱相关。
Hum Mol Genet. 2025 Mar 7;34(6):547-562. doi: 10.1093/hmg/ddaf006.
6
Oligodendrocytes, the Forgotten Target of Gene Therapy.少突胶质细胞——基因治疗中被遗忘的靶点
Cells. 2024 Nov 28;13(23):1973. doi: 10.3390/cells13231973.
7
Liver SMN restoration rescues the Smn mouse model of spinal muscular atrophy.肝脏中生存运动神经元(SMN)的恢复挽救了脊髓性肌萎缩症的 Smn 小鼠模型。
EBioMedicine. 2024 Dec;110:105444. doi: 10.1016/j.ebiom.2024.105444. Epub 2024 Nov 7.
8
Glucose and Lipid Metabolism Disorders in Adults with Spinal Muscular Atrophy Type 3.3型脊髓性肌萎缩症成人患者的糖脂代谢紊乱
Diagnostics (Basel). 2024 Sep 19;14(18):2078. doi: 10.3390/diagnostics14182078.
9
Recent Progress in Gene-Targeting Therapies for Spinal Muscular Atrophy: Promises and Challenges.脊髓性肌萎缩症基因靶向治疗的最新进展:前景与挑战。
Genes (Basel). 2024 Jul 30;15(8):999. doi: 10.3390/genes15080999.
10
Risdiplam Real World Data - Looking Beyond Motor Neurons and Motor Function Measures.Risdiplam 真实世界数据——超越运动神经元和运动功能评估。
J Neuromuscul Dis. 2024;11(1):75-84. doi: 10.3233/JND-230197.